Office of the Commissioner of Lobbying of Canada Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

Monthly Communication Reports in: October 2018

Other options for searching the Registry: 12-Month Lobbying Activity Search; Advanced Registry Search; Recent Registrations; and Recent Monthly Communication Reports.

The list below is sorted by communication date, beginning with the most recent.

Eli Lilly Canada Inc.

Lisa Matar, President and General Manager (Corporation)

Results 1-5 of 5

  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)

    Subject Matter of the communication: Health, Industry
    Communication date: 2018-10-25
    Posted date: 2018-11-01
    Communication number: 6034-436876 View associated registration
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Gianluca Cairo, Chief of Staff to Minister Bains | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Research and Development
    Communication date: 2018-10-23
    Posted date: 2018-11-09
    Communication number: 6034-437542 View associated registration
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • John Knubley, Deputy Minister, ISED | ISED | Innovation, Science and Economic Development Canada (ISED)
    • Mark Schaan, Director General, Market Framework Policy branch | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Research and Development
    Communication date: 2018-10-23
    Posted date: 2018-11-09
    Communication number: 6034-437537 View associated registration
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Daniel Albas, Opposition on Innovation, Science and Economic Developement Critic | House of Commons

    Subject Matter of the communication: Health, Research and Development
    Communication date: 2018-10-23
    Posted date: 2018-11-09
    Communication number: 6034-437545 View associated registration
  • Eli Lilly Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Mark Schaan, Director General | Marketplace Framework, Policy Branch | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Intellectual Property
    Communication date: 2018-10-03
    Posted date: 2018-11-01
    Communication number: 6034-436875 View associated registration

Return to Monthly Communication Reports by Reporting Period

Date Modified: